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Foot drop is a common gait impairment in peoplewithMS (pwMS) but in some foot dropmay only occur after a period of prolonged
walking and may be a sign of motor fatigability. The purpose of the study was to explore whether, for pwMS, an adapted six-
minute walk test (6minWT)would result in an increase in foot drop asmeasured using electrogoniometry. Sagittal ankle kinematics
were recorded for fifteen participants (10 females and 5 males, aged 37-64) with MS (EDSS 4-6) throughout the 6minWT. Ankle
kinematics and temporal stride parameters were compared between the first and last 10 gait cycles of the 6minWT. Peak dorsiflexion
in swing was significantly reduced at the end of the 6minWT compared to the start, with six of the fifteen participants having a
decrease of two degrees or more. Statistically significant changes in temporal stride parameters suggested a decrease in walking
speed. Our results suggest that with the protocol used in this study it is feasible to identify patients who experience increased foot
drop as a result of a prolonged exercise task.
1. Introduction
Multiple sclerosis (MS) is an autoimmune disease charac-
terized by inflammation and progressive destruction of the
central nervous system (CNS). The disease usually presents
between the ages of 20-40 and affects around 2.3 million
people worldwide [1]. Although symptom manifestation can
vary considerably among individuals, the cluster of symp-
toms comprising fatigue, weakness, posture, and movement
disturbances is common [2]. Heesen et al. [3] reported that
gait functionwasmost frequently rated as themost important
domain by people withMS (pwMS). Both the prevalence and
severity of gait impairments have been found to correlate
with the duration of the disease, although some studies
have identified walking characteristics that are affected in
people with mild MS [4, 5]. A common gait symptom is foot
drop, which is a decrease in ankle dorsiflexion during the
swing phase of gait, resulting in an increased likelihood for
tripping and falling. Foot drop can be caused by peripheral
muscle weakness of the dorsiflexor muscles, increased tone
of the plantar flexor muscles, or impaired neural control
causing cocontraction of agonist and antagonist muscles
[6]. Particularly in pwMS foot drop may also be a sign of
increased motor fatigability [7]. In this case, foot drop may
not manifest itself when the patient is performing a short
walk test (e.g., 10 meters) in the clinic but will only occur
after a certain period of prolonged walking the duration of
which varies among individuals. In a qualitative study on
the experiences of assistive technology (Functional Electrical
Stimulation and Ankle Foot Orthosis) to treat foot drop,
some participants commented that they only used thesewhen
going out for longer walks [8].
As a consequence, this type of foot drop which only
occurs occasionally or worsens as a result of prolonged
exercise and is likely to be a sign of motor fatigability may
be difficult to diagnose in short duration walking tests.
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Similarly, for some patients the benefits of therapy or assistive
technology to treat foot dropmay only be evident over longer
duration walking tests.
Kluger et al. [9] described fatigability as an exercise-
induced reduction in the ability of muscles to produce force
or power, regardless of whether a task can be sustained.
Several authors have suggested that this reduced performance
over time is partly of central origin [10–13] and could be a
compensatorymechanism for the effects of demyelination on
conduction in motor pathways in people with MS.
Severijns et al. [14] reviewed the protocols and outcome
measures used to study or detect motor fatigability in pwMS.
They concluded that motor fatigability, assessed either at
International Classification of Functioning, Disability and
Health (ICF) body function level (e.g., strength) or at the ICF
activity level (e.g., walking performance), is increased inmost
pwMS.
Previous studies evaluating motor fatigability on ICF
activity level have done so bymeasuring the decrease in walk-
ing speed over the duration of a set walking test ranging from
6 to 12 minutes or a specified distance, e.g., [15–18]. However,
only a few research groups have investigated fatigability on
the ICF activity level by quantifying the deterioration in gait
kinematics [19–22]. Computerised 3Dmotion analysis is able
to detect even small changes in gait kinematics that cannot
be observed visually. Unfortunately however, this technique
can be impractical for routine clinical practice due to issues
associated with equipment cost and need for specialist staff
to collect and interpret 3D data. Flexible electrogoniometry
(EGM) has been proposed as a valid alternative method
by which to record gait kinematics [23, 24] in a clinical
environment.
The primary aim of this pilot study was therefore to deter-
mine whether an adapted 6-minute walking test (6minWT)
protocol combined with electrogoniometry could be used
to detect a decrease in ankle dorsiflexion during swing
suggesting motor fatigability.
As such, this studywill indicatewhether the protocol used
in this study may be used to detect foot drop due to motor
fatigability in a clinical environment. The secondary aim of
this study was to assess whether temporal stride parameters
(cadence and stance phase duration) and the rate of perceived
exertion (RPE) change over the duration of 6 minutes of
walking.
2. Materials and Methods
The experiment took place in a single visit to either the
outpatient physiotherapy clinic or the university sports hall.
The study was approved by the research ethics committees
of the United Kingdom National Health Service (NHS) and
Queen Margaret University. Participants provided informed
consent prior to taking part in the study in accordance with
the declaration of Helsinki.
2.1. Participants. Participants with a clinical diagnosis of
definite MS according to the McDonald criteria [25] were
included in the study if they presented with unilateral foot
Figure 1: Data logger and position of the electrogoniometer end
blocks on the lateral surface of the lower leg and shoe.
drop due to MS as diagnosed by an experienced specialist
physiotherapist.The exclusion criteria were fixed ankle defor-
mities, allergy to tape, and being unable to walk for at least
twominutes without stopping (with or without walking aids).
Patients with other conditions affecting their walking ability
such as cardiopulmonary disease, severe visual loss and
arthritis, and particularly conditions which possibly could
result into foot drop such as peripheral neuropathies and
disorders of the spine were also excluded.
Participants were recruited from an outpatient physio-
therapy clinic.
2.2. Procedure/Outcome Measures. Prior to their walking
assessment, all participants completed the MS walking scale
(MSWS-12) which is a patient-reported outcome measure of
perceived walking ability. It contains 12 questions/items with
the original scoring providing 1-5 points for each item, with ‘1’
meaning ‘no limitation’ and ‘5’ meaning ‘extreme limitation’.
A total score is generated and reported on a 0 to 100 scale [26]
with a higher score indicating a higher reported limitation of
walking ability.
The two end blocks of the ankle electrogoniometer
(SG110A, Biometrics Ltd., Newport, UK) were attached to
the lower leg and shoe using skin-friendly double sided
adhesive tape according to the manufacturer’s instructions
(see Figure 1). The electrogoniometer was attached to the leg
for which the participant received treatment for foot drop.
A pressure sensitive sensor (‘foot switch’) was attached to
the sole of the participant’s heel to record the instant of heel
contact, which allows the identification of the gait cycle (heel
contact to ipsilateral heel contact).
Both the electrogoniometer and the foot switch were con-
nected to a data logger which recorded the ankle kinematics
and foot switch data synchronously at 100 Hz. During the
assessment the participant carried the data logger in a waist
belt.
In an adapted 6-minute walking test protocol, partici-
pants were instructed to walk around a rectangular course
of 32 metres in length (10m long and 6m wide) and cover
as much distance as possible over a period of 6 minutes.
The number of laps were counted and the position of the
participant at the end of the 6minWT was marked on the
floor with tape, allowing the calculation of the total distance
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Figure 2: Typical sagittal ankle joint angle over one complete gait
cycle showing the outcome measures AAIC (ankle angle at initial
contact), DFswing (peak dorsiflexion in swing), and the timing of
peak plantar flexion (PFtim), reported as % of gait cycle.
walked. Participants were informed that they could stop and
rest if they felt they needed to. Participants were asked towear
their usual flat-soled walking shoes or trainers and removed
their AFO or switched off their FES device for the duration of
the test.
At every minute after the start of the 6minWT, the
participant was asked to rate his or her perceived exertion
using the Borg Rate of Perceived Exertion (Borg RPE) scale
which is a 15-point rating scale ranging from 6 to 20, with 6
‘no exertion’ to 20 ‘maximal exertion’ [27].
2.3. Data Analysis. Data analysis was performed using
custom-written scripts in Matlab v7.6.0 (Mathworks, Natick
MA, USA). The following gait parameters were derived from
the electrogoniometry and foot switch data: peak dorsiflexion
during swing (DFswing), ankle angle at initial contact (AAic),
cadence (steps/min), and the instant of the peak plantar flex-
ion just before toe-off (PFtim) calculated as the percentage
of the duration of the gait cycle (Figure 2). PFtim was used
as an approximation of the duration of the stance phase as
the instant of toe-off occurs just after PFtim [28]. All gait
parameters were determined for each of the first and last 10
gait cycles of the 6minWT for each participant.
2.4. Statistical Analysis. Normality of the gait data was
confirmed by visual inspection of the q-q plots and box plots
and the Shapiro-Wilk test. Differences between gait charac-
teristics in the first and last 10 gait cycles of the 6minWTwere
analysed using paired t-tests. For the RPE the values reported
in the 1st minute of the 6minWT were compared to those in
the last minute of the 6minWT. A p-value of less than 0.05
was regarded as statistically significant. Statistical analysis
was performed using SPSS v21 (IBM Software, Armonk NY,
USA).
3. Results
Fifteen participants were recruited and attended the QMU
sports hall or outpatient physiotherapy clinic for one single
Table 1: Participant (n=15) characteristics, objective, and self-
reported walking performance.
Mean ± SD (range)
Age in years ± SD (range) 54.9 ± 7.7 (37 – 64)
Males: females 5: 10
EDSS range 4-6
Type of MS (RR, PP, SP) 4/7/4
FES/AFO/none 10/2/3
MSWS-12 (range 0-100) 72 ± 15 (50-90)
6minWT (m) 263 ± 79 (107-391)
Walking speed (m/s) during 6minWT∗ 0.77(0.20)
∗n=12; excluding the three participants who stopped during the 6minWT.
assessment. Participants’ descriptive characteristics are pre-
sented in Table 1.Three of the fifteen participants paused for a
maximum of 5 minutes because mobility issues such as lower
limbweakness during the 6minWTbut all completed the test.
The results for the gait characteristics and RPE are shown
inTable 2. Compared to the start of the 6minWT, therewas an
average decrease of 1.4 and 1.6 degrees at the end of 6minWT
for the AAic and DFswing, respectively, but this was only
statistically significant for DFswing (p=0.03).
If analysing the results of only those who did not stop
during the 6minWT (n=12), the average decrease over the
duration of the 6minWT for the AAic and DFswing was less
than for the whole sample; 1 and 1.4 degrees, respectively, and
neither decrease was statistically significant.
Cadence was significantly reduced at the end of the
6minWT compared to the start (p<0.001). The timing of the
peak plantar flexion as a percentage of the duration of the
gait cycle used as a proxy for stance phase duration was also
significantly later (p=0.02) at the end of the 6minWT. Both
a reduced cadence and a longer stance phase duration are
associated with a decrease in walking speed.
Finally, the RPE in the sixth minute of the 6minWT was
significantly higher than the RPE after oneminute (12.1 versus
7.9, p<0.001)
The results at an individual level (averaged over 10 gait
cycles) can be seen in Table 3. Six of the 15 participants had
a decrease in dorsiflexion in swing of two degrees or more
[29] (average 3.7∘, range 2-7∘). Of those six, three stopped
briefly during the 6minWT.On average, those six participants
also tended to have a more severe degree of foot drop at
the start of the 6minWT (4∘ of plantar flexion) compared to
those who did not (2∘ of dorsiflexion). Twelve of the fifteen
participants showed a decrease in cadence over the duration
of the 6minWT (Table 3).
4. Discussion
Themain purpose of the present studywas to explorewhether
an adapted 6minWT would lead to a decrease in ankle
dorsiflexion, suggesting motor fatigability, in people withMS
with a clinical diagnosis of foot drop.
It was found that the average decrease in peak dorsiflexion
in swing of 1.5 degrees was statistically significant and that six
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Table 2: Means (SD) of the gait characteristics and RPE in the first and last 10 gait cycles of the 6minWT.
First 10 gait cycles Last 10 gait cycles p-value
Ankle angle at IC (∘) -7.6 (4.6) -9.0 (6.2) 0.13
Peak dorsiflexion in swing(∘) -0.4 (7.6) -2.0 (8.7) 0.03
Cadence(steps/min) 49(6) 46(7) <0.001
Timing peak plantar flexion (%GC) 66 (2) 69(3) 0.02
RPE (range 6-20) 7.9 (1.8) 12.1 (2.4) <0.001
IC=initial contact;%GC=% gait cycle duration; RPE=rate of perceived exertion.
Table 3: Individual results for all participants.
Participant MSWS12 6minWT (m) DFswing(∘) first 10 GC Change DFswing(∘) Change in cadence (steps/min)
1 80 197 0.3 -3.7 -4
2 90 224 -4.9 1.6 -4
3 80 326 1.7 2.1 -5
4 70 107 -11.8 -1.8 -2
5 63 333 12.8 -0.8 -3
6 65 391 -0.6 -2.1 -1
7 73 191 10.8 -0.6 -8
8 87 216 10.8 1.3 -3
9 73 309 1.3 -1.5 0
10 90 179 -5.6 1.1 -5
11 82 295 -1.1 -6.7 -1
12 67 262 3.0 -1.9 2
13 50 263 -12.2 -3.3 -5
14 85 266 -4.1 -2.3 0
15 68 386 -6.5 -4.6 -2
of the fifteen participants had a decrease of 2 degrees of more,
which can be regarded as clinically significant [29].
Our finding that not all participants exhibited a deteri-
oration in gait kinematics over the duration of the walking
test agrees with the findings of Sehle et al. [20]. Using a
preestablished cut-off value, based on their Fatigue index
Kliniken Schmieder (FKS) derived from gait kinematics,
these authors reported that just over 70% of their participants
exhibited motor fatigue over an exercise task which involved
walking until a RPE of 17 (‘very hard’) was achieved or until
60 minutes had elapsed.
The participants in the study by McLoughlin et al. [21]
underwent computerised 3D gait analysis of three walking
trials just before and after a 6minWT. In the trials directly
following the 6minWT, statistically significant decreases in
peak dorsiflexion in swing and the angle ankle at initial
contact were observed. Interestingly, although the average
change in dorsiflexion reported was similar to that in our
study (1.5 degrees), participants in Mcloughin’s study [21]
exhibited considerably less foot drop before the 6minWT
(mean of 8∘ of peak dorsiflexion in swing, compared to 2∘ of
plantar flexion in our study).
The majority of the studies assessing motor fatigability
in people with MS have focused on the decrease in walking
speed [15–18] over a set distance or time. In a large multi-
centre trial (n=208), Leone et al. [18] found that the majority
of participants (EDSS 3.5-5.5) showed a continuous decrease
(more than 5%) in walking speed over the duration of the
6minWT (31 out 54 participants (57%) and 19 out of 29 (66%)
for EDSS 3-4 and EDSS 4.5-5.5, respectively). Phan-Ba et al.
[16] recorded the time required to cover 100m during a 500m
walk test in a large number of pwMSwith EDSS ranging from
0 to 6. Compared to the first 100 m, pwMS with EDSS <4
slowed downonly slightlymore than the healthy controls (3-4
s versus 2 s); however the groupwith EDSS 4-6was 15 seconds
slower in their last 100m lap compared to the first lap. Finally,
Dalgas et al. [17] showed that the first minute of the 6minWT
was fastest and followed by a stable walking speed for people
mildly affected byMSbut a continuous decline duringminute
2-5 for those moderately affected by MS.
Althoughwedid not directly recordwalking speed during
the 6minWT, our findings of a reduced cadence and increased
duration of the stance phase during the last 10 gait cycles of
the 6 minute walk also suggested a decrease in walking speed
in 12 of the 15 participants.
In contrast, the participants in the studies byMcLoughlin
et al. [21] and Barr et al. [22] did not show a decrease
in walking speed. The fact that these studies recorded the
walking speed directly before and after, rather than during the
6minWT, and their inclusion of participants whose walking
ability was only mildly impaired (average walking speed
1.16 m/s versus 0.77 m/s in our study) could explain the
comparative discrepancy in results.
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Compared to studies quantifying fatigability by a decrease
in walking speed, we believe the strength of our study
and those studies by McLoughlin et al. [21] and Sehle et
al. [19, 20] is the quantification of fatigability at the ICF
activity level using gait kinematics before and after or during
a fatiguing task rather than walking speed. A focus on
gait kinematics may potentially provide more insight into
the mechanisms involved with motor fatigability as walking
speed during prolonged walking can be influenced by many
other factors such as pacing strategies [17] and aerobic
fitness.
The main limitation of our study and the majority of
other studies investigating motor fatigability in people with
MS are the use of one set exercise task (i.e., 6 min walk test)
for all participants irrespective of their walking capacity. It is
possible that tests with longer duration and/or a higher inten-
sity more closely resembling tasks in activities of daily living
would have elicited a decrease ankle dorsiflexion in more
participants. Further, the test- retest reliability of the change
in ankle kinematics over the duration of a 6minWT was not
assessed. This lack of information regarding the test-retest
reliability of motor fatigability measures was highlighted in
a recent systematic review [14] and should be addressed in
future studies.
Another potential limitation of our study is the relatively
small number of participants. However, the statistical power
of our study was sufficient to detect statistically significant
differences in temporal stride parameters and a relatively
small mean change (1.5 degrees) in ankle dorsiflexion. A
larger sample may have resulted in more statistically signifi-
cant changes but these changesmay have not been necessarily
clinically significant.
Further, for safety reasons, we allowed our participants to
stop and rest before continuing the 6minWT. It is possible that
this allowed those participants to recover and thus show no
or a reduced decrease in ankle dorsiflexion indicating motor
fatigability. However, all three participants who stopped
showed a decrease in dorsiflexion in swing ranging from 1.5
to 3.5∘ at the end of the 6minWT.
Other limitations include the use of a single ankle
electrogoniometer; hence we were not able to ascertain
whether motor fatigability, as defined as a deterioration in
gait kinematics, is also apparent in joints other than the
ankle and in the contralateral leg. Although the participants
had a clinically diagnosed foot drop in only one leg, it is
possible that participants also had a degree of neurological
deficit in the other leg, negatively affecting the participant’s
gait characteristics such as stride time over the duration of
the 6minWT. Similarly, impaired core stability and balance
deficits could have becomemore prominent at the end of this
task which involved four 90-degree turns over a distance of
32m.However, the focus of this studywas on ankle kinematics
in swing which may be less likely to be influenced by factors
such as impaired balance and neurological deficits of the
contralateral leg.
Finally, our study did not include an age matched control
group so that we cannot be sure that the observed changes
in gait pattern over the duration of the 6minWT are not also
present in aged matched people without MS.
Future studies should address these aforementioned lim-
itations in order to obtain a better understanding of the onset
or worsening of foot drop after prolonged exercise as a sign
of motor fatigability in people with MS.
5. Conclusion
The aim of the present study was to investigate whether an
adapted 6minWTprotocol would result in a decrease in ankle
dorsiflexion as an outcome of motor fatigability in pwMS
with clinically diagnosed foot drop. We found an average
decrease in dorsiflexion of 1.5 degrees which was statistically
significant and that 6 of the 15 participants showed a clinically
significant decrease of 2 degrees or more.
Our results suggest that with the protocol used in this
study it is feasible to identify patients who experience
increased foot drop as a result of a prolonged exercise task
without the need for a computerised 3D gait analysis system.
Our observations have implications for clinical practice with
respect to both the diagnosis of foot drop and the assessment
of the efficacy of interventions treating foot drop in those
patients whose ankle kinematics over a short distance are
not or minimally affected. It is recommended that future
studies assess the test-retest reliability of measures of motor
fatigability.
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